267 related articles for article (PubMed ID: 18190288)
1. Pathogenesis of HIV disease: opportunities for new prevention interventions.
Fauci AS
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S206-12. PubMed ID: 18190288
[TBL] [Abstract][Full Text] [Related]
2. [The HIV pandemic in the year 2007, an overview].
Bartelsman M; Veeken H
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2655-60. PubMed ID: 18179081
[TBL] [Abstract][Full Text] [Related]
3. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
Gaym A
Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
[TBL] [Abstract][Full Text] [Related]
4. Recent efforts in biomedical prevention of HIV.
Landovitz RJ
Top HIV Med; 2007; 15(3):99-103. PubMed ID: 17598929
[TBL] [Abstract][Full Text] [Related]
5. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
Abbas UL
Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
[TBL] [Abstract][Full Text] [Related]
6. Environmental factors in HIV/AIDS epidemic development: new perspectives for gender equity and global protection against HIV transmission.
Alfsen A
Ann N Y Acad Sci; 2004 Jun; 1023():164-74. PubMed ID: 15253905
[TBL] [Abstract][Full Text] [Related]
7. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in HIV pathogenesis and treatment.
Gupta G
J Calif Dent Assoc; 2001 Feb; 29(2):129-35. PubMed ID: 11324112
[TBL] [Abstract][Full Text] [Related]
10. [Sexual transmission of HIV: effect of potent antiretroviral therapy].
Vernazza PL
Ther Umsch; 1998 May; 55(5):285-8. PubMed ID: 9643125
[TBL] [Abstract][Full Text] [Related]
11. The role of prevention research in HIV vaccine trials.
Vermund SH
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S303-5. PubMed ID: 7865326
[TBL] [Abstract][Full Text] [Related]
12. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
Lederman MM; Offord RE; Hartley O
Nat Rev Immunol; 2006 May; 6(5):371-82. PubMed ID: 16639430
[TBL] [Abstract][Full Text] [Related]
13. Microbicides: a new approach to preventing HIV and other sexually transmitted infections.
Stone A
Nat Rev Drug Discov; 2002 Dec; 1(12):977-85. PubMed ID: 12461519
[TBL] [Abstract][Full Text] [Related]
14. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
15. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?
Hosseinipour M; Cohen MS; Vernazza PL; Kashuba AD
Clin Infect Dis; 2002 May; 34(10):1391-5. PubMed ID: 11981736
[TBL] [Abstract][Full Text] [Related]
16. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
17. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.
Eyakuze C; Jones DA; Starrs AM; Sorkin N
Dev World Bioeth; 2008 Apr; 8(1):33-42. PubMed ID: 18315723
[TBL] [Abstract][Full Text] [Related]
18. Broadening inclusion of vulnerable populations in HIV vaccine trials.
Lau CY; Cardinali M; Sato PA; Fix A; Flores J
Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of vertical transmission of HIV in Denmark].
Rasmussen MB; Rasmussen JB; Nielsen VR; Herlin T; Fisker N; Hornstrup MK; Vinter H; Olofsson M; Weis NM
Ugeskr Laeger; 2008 Aug; 170(34):2567-70. PubMed ID: 18761841
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
das Neves J; Amiji MM; Bahia MF; Sarmento B
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):458-77. PubMed ID: 19914314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
